Principal Investigator:
David I Hirsh Phd
Award Amount:
$440,212.00
Synergen, inc.'s proposed research will develop, through recombinant dna methods, new agents to control dental plaquethese will consist of an enzymatic moiety of therapeutic value fused wih an adhesive peptide that binds specifically and strongly to dental surfaces. the latter are termed adheson…
More